Related Experiment Videos
The ultraflex diamond stent for benign biliary obstruction
J M Dumonceau1, N Nicaise, J Devière
1Department of Gastroenterology and Hepato-Pancreatology, Erasme University Hospital, Brussels, Belgium.
Gastrointestinal Endoscopy Clinics of North America
|July 2, 1999
Summary
This study explored the Ultraflex Diamond stent for treating benign bile duct strictures (BBDS) related to chronic pancreatitis. Preliminary results show no stent dysfunction over 17 months, suggesting potential for endoscopic treatment.
Area of Science:
- Gastroenterology
- Interventional Endoscopy
- Biliary Tract Diseases
Background:
- Benign bile duct stricture (BBDS) is a complication of surgery, chronic pancreatitis (CP), and radiotherapy.
- Current metal stents have poor long-term results for frequent BBDS types.
- Less frequent BBDS types, like those from CP, may benefit from alternative treatments.
Purpose of the Study:
- To evaluate the preliminary outcomes of using the Ultraflex Diamond stent for CP-related BBDS.
- To assess the safety and efficacy of endoscopic stenting in this patient group.
Main Methods:
- Retrospective analysis of 10 patients with CP-related BBDS.
- Treatment with Ultraflex Diamond stent.
- Mean follow-up of 17 months.
Main Results:
- No stent dysfunction was observed in any of the 10 patients.
- The Ultraflex Diamond stent demonstrated promising short-term results in this cohort.
Conclusions:
- Endoscopic treatment with the Ultraflex Diamond stent is a potential option for CP-related BBDS.
- Further studies with larger patient numbers and longer follow-up are needed to confirm efficacy and compare with surgical options.